NCT05050487 is a NA clinical trial of PENG block in Post Operative Pain, Chronic, sponsored by Assiut University.

Who is sponsoring NCT05050487?

NCT05050487 is sponsored by Assiut University.

What drugs are being tested in NCT05050487?

Interventions in NCT05050487: PENG block, lumbar erector spinae plane block.

What condition does NCT05050487 study?

NCT05050487 studies Post Operative Pain, Chronic.

Is NCT05050487 still recruiting?

NCT05050487 is currently status unknown. Last updated 28 April 2022.

Last reviewed 2022-04-28 · How we verify

NCT05050487

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pericapsular Nerve Group Block Versus Lumber Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty

Status unknown NA Last updated 28 April 2022

What this trial tests

NA trial testing PENG block in Post Operative Pain, Chronic in 60 participants. Status unknown.

Timeline

30 June 2022

Primary endpoint
30 October 2023

30 December 2023

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	30 June 2022
Primary completion	30 October 2023
Estimated completion	30 December 2023

Drugs / interventions tested

PENG block — full drug profile →
lumbar erector spinae plane block

Conditions studied

Post Operative Pain, Chronic — all drugs for Post Operative Pain, Chronic →

Sponsor

Assiut University

Who can join

Adults 18 to 80, any sex, with Post Operative Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pain is a major problem that has to be dealt with in case of hip fracture, as it presents an obstacle for examination, positioning for receiving neuroaxial anesthesia and postoperative mobility and physiotherapy. With the introduction of ultrasound in regional anesthesia and peripheral nerve blocks, regional analgesia float to the surface as a substitute for opioids with less side effects Lumbar erector spinae plane block has emerged as a reliable analgesic option for primary total hip arthroplasty (THA). In 2018, a new block was described, termed pericapsular nerve group block or PENG block, that selectively targets the articular branches of the femoral and obturator nerves while sparing their motor components

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PENG block

Trials testing the same drug.

NCT07442721 — Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia · NA · recruiting
NCT07061223 — SFIB vs PENG Block in the Anesthesia for Total Hip Replacement · NA · enrolling by invitation
NCT06993376 — PENG Block vs ESPB in Elderly Undergoing Hip Surgeries · NA · not yet recruiting
NCT06795724 — Effect of Peng Block Application on Inflammation and Mortality in Hip Fractures · NA · completed
NCT06677606 — PENG Block in Comparison With Anesthetic Infiltration (PAI) After Hip Hemiarthroplasty · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05050487 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 28 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05050487.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing